Anderson Raymond

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 121%
Success rate 73%
Average holding period 220
Transactions 28
Anderson Raymond's trades of Monopar Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
0.43
Quantity 40,123
Value £17,253
Transaction date
Purchase
Price
1.04
Quantity 30,372
Value £31,572
Transaction date
Sale
Price
2.32
Quantity 600,000
Value £1,389,000
Transaction date
Purchase
Price
1.12
Quantity 15,000
Value £16,800
Transaction date
Purchase
Price
0.80
Quantity 20,909
Value £16,727
Transaction date
Purchase
Price
1.80
Quantity 5,556
Value £10,001
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-27 2026-08-25 PlS Planned sale
59,054 +21.3%
295.46
US$4,481,247
59,054 +21.3% 295.46 US$4,481,247
2026-08-27 2026-08-25 PlS Planned sale
17,324 +12.3%
385.56
US$4,825,717
17,324 +12.3% 385.56 US$4,825,717
2026-08-27 2026-08-25 PlS Planned sale
84,918 -15.5%
60.17
US$4,710,026
84,918 -15.5% 60.17 US$4,710,026
2026-08-25 2026-08-25 PrS Proposed sale
6,284
111.36
US$699,786
6,284 111.36 US$699,786
2026-02-11 2026-02-09 S Sale
40,123
0.43
£17,253
40,123 0.43 £17,253
2024-01-29 2024-01-26 B Purchase
30,372
1.04
£31,572
30,372 1.04 £31,572
2023-02-17 2023-02-16 S Sale
600,000
2.32
£1,389,000
600,000 2.32 £1,389,000
2020-01-06 2020-01-06 B Purchase
15,000
1.12
£16,800
15,000 1.12 £16,800
2019-06-24 2019-06-24 B Purchase
20,909
0.80
£16,727
20,909 0.80 £16,727
2018-01-24 2018-01-24 B Purchase
5,556
1.80
£10,001
5,556 1.80 £10,001